The Telegraft is the leading global cell therapy newsletter. It is provided as a benefit of ISCT membership both in print and online. It is also used as a promotional vehicle for ISCT activities.
The Telegraft provides those in or interested in the cell therapy community with current information on new developments, items of interest, regulatory updates, and regular columns on related meetings, organizations, and events, summaries of work being done in both academic and industry labs around the world, and much more. Special issues are also published as required to cover developments of particular importance or interest to the membership.
This quarterly magazine membership includes insightful discussions and up-to-date information on critical issues affecting the field of cellular therapy.
|
